10.62
0.00%
Close of 9 Nov 2026, in CHF
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About medmix
Its shares trade on SIX under the ticker MEDX.SW. It has been listed since 30 September 2021. In the fiscal year to 31 December 2025, it reported revenue of CHF 448.0m and net income of CHF 6.4m. At that date it held total assets of CHF 969.3m and shareholders' equity of CHF 425.7m.
medmix AG designs, develops and produces delivery devices for the mixing, application and injection of liquids for the healthcare, consumer and industrial end-markets. The company is headquartered in Baar, Zug. The company went IPO on 2021-09-30. The firm operates in business areas such as: the dental segment, which provides MIXPAC and transcodent - system solutions that are used to dose, mix and apply various types of dental materials; drug delivery- solutions for the dosage and application of drugs; a surgical segment which provides devices for bone regeneration and tissue healing; an industry segment that specializes in the mixing and dosing of sealants and adhesives through IXPAC , COX and MK; and a beauty segment in which it produces cosmetic applicators through the GEKA brand.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 30 Sept 2021
- Employees
- 2,101
- Website
- medmix.ch ↗
Leadership
Pay as last reported
- Mr. Rob Ten HoedtNon-Executive Chairman of the BoardCHF 322,000
- Dr. Rene WilliChief Executive Officer, Member of the Executive Committee, since 2022CHF 3.6m
- Mr. Marco MusettiNon-Executive Vice Chairman of the BoardCHF 158,000
- Ms. Jennifer DeanChief Financial Officer, Member of the Executive Committee
- Ms. Itee SatpathyChief Human Resources, Sustainability Officer, Member of the Executive Committee
- Mr. Xavier SchopsChief Legal Officer, Company Secretary, Head of Corporate Affairs, Member of the Executive Committee
- Ms. Barbara AngehrnMember of the Board of DirectorCHF 140,000
- Mr. Daniel FlammerMember of the Board of DirectorCHF 140,000
- Ms. Susanne Hundsbaek-PedersenMember of the Board of DirectorCHF 119,000
- Mr. David MetzgerMember of the Board of DirectorCHF 140,000
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Medmix AG has a strong reputation in the medical industry.
- The company has a diverse and highly skilled workforce.
- Medmix AG possesses advanced technological capabilities.
- The company has established strong relationships with key stakeholders.
Weaknesses
- Medmix AG has limited market presence compared to its competitors.
- The company faces challenges in expanding its customer base.
- Medmix AG has limited financial resources for extensive research and development.
- The company lacks patent protection for some of its products.
Opportunities
- Growing demand for advanced medical technologies presents opportunities for Medmix AG.
- The company can expand its market presence by targeting emerging markets.
- Advancements in healthcare policies create opportunities for Medmix AG's products and services.
- Collaboration with strategic partners can lead to new business opportunities for Medmix AG.
Threats
- Intense competition from established market players poses a threat to Medmix AG.
- Rapid technological advancements may render some of Medmix AG's products obsolete.
- Changes in healthcare regulations and policies can impact the company's operations.
- Economic downturns and market uncertainties may affect Medmix AG's financial stability.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.